I'm LongbridgeAI, I can summarize articles.Danaher Corp. (DHR) stock rose 1.55% to $203.25, outperforming the broader market which saw declines in the S&P 500 and Dow Jones. This gain ended a five-day losing streak for Danaher. However, compared to competitors like Thermo Fisher Scientific, Abbott Laboratories, and Medtronic, Danaher's performance was mixed as those peers also posted gains. Trading volume remained below its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Danaher Corp. (DHR) advanced 1.55% to $203.25 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.48% to 7,619.98 and Dow Jones Industrial Average falling 0.29% to 52,421.20.
The stock's rise snapped a five-day losing streak.
Danaher Corp. closed 16.29% below its 52-week high of $242.80, which the company achieved on January 22nd.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Thermo Fisher Scientific Inc. (TMO) rose 0.62% to $613.62, Abbott Laboratories (ABT) rose 1.12% to $103.09, and Medtronic PLC (MDT) rose 3.12% to $93.80.
Trading volume (3.4 M) remained 1.2 million below its 50-day average volume of 4.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-14-26 1636ET